To investigate the correlation between ALKBH5 expression and GBM prognosis, we conducted a Kaplan–Meier survival analysis of two GBM datasets—one from the Chinese Glioma Genome Atlas (CGGA) and another from Nanfang Hospital (based on immunohistochemistry [IHC] staining score). The gene discussed is ALKBH5; the disease is glioma.